Patents by Inventor Raffaele Del Buono

Raffaele Del Buono has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions including alginates and methods of preparing and using same
    Patent number: 7776839
    Abstract: A pharmaceutical composition is provided for use in the healing of cells containing about 0.0001 percent weight per volume (% w/v) to about 2% w/v of an alginic acid or a salt of alginic acid having a molecular weight in the range of greater than about 250,000 to about 1,000,000, provided that if the composition additionally contains an alginic acid or a salt of alginic acid having a molecular weight in the range of about 20,000 to about 250,000, it is present in an amount of less than 1% w/w. The use of the pharmaceutical composition for the healing cells in a mammal, preferably mucosal cells is also provided.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: August 17, 2010
    Assignee: Reckitt Benckiser Healthcare (UK) Limited
    Inventors: Raffaele Del Buono, Peter William Dettmar, Frank Chadwick Hampson, Ian Gordon Jolliffe, Paul Murray McPherson, Edvar Onsoyen, Massimo Pignatelli, Peter Edward Ross
  • Pharmaceutical compositions including alginates and methods of preparing and using same
    Publication number: 20030130229
    Abstract: A pharmaceutical composition is provided for use in the healing of cells containing about 0.0001 percent weight per volume (% w/v) to about 2% w/v of an alginic acid or a salt of alginic acid having a molecular weight in the range of greater than about 250,000 to about 1,000,000, provided that if the composition additionally contains an alginic acid or a salt of alginic acid having a molecular weight in the range of about 20,000 to about 250,000, it is present in an amount of less than 1% w/w. The use of the pharmaceutical composition for the healing cells in a mammal, preferably mucosal cells is also provided.
    Type: Application
    Filed: September 10, 2002
    Publication date: July 10, 2003
    Applicant: Reckitt Benckiser Healthcare (UK) Limited
    Inventors: Raffaele Del Buono, Peter William Dettmar, Frank Chadwick Hampson, Ian Gordon Jolliffe, Paul Murray McPherson, Edvar Onsoyen, Massimo Pignatelli, Peter Edward Ross